Cubist Systematic Strategies’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26,734
| Closed | -$2.98M | – | 4186 |
|
|
2023
Q3 | $3M | Buy |
26,734
+20,496
| +329% | +$2.6M | 0.02% | 1079 |
|
|
2023
Q2 | $908K | Sell |
6,238
-36,530
| -85% | -$4.96M | 0.01% | 2015 |
|
|
2023
Q1 | $5.53M | Buy |
42,768
+29,246
| +216% | +$3.67M | 0.03% | 845 |
|
|
2022
Q4 | $1.72M | Buy |
13,522
+5,962
| +79% | +$692K | 0.01% | 1975 |
|
|
2022
Q3 | $790K | Sell |
7,560
-59,023
| -89% | -$6.48M | ﹤0.01% | 2816 |
|
|
2022
Q2 | $7M | Buy |
66,583
+59,125
| +793% | +$7.01M | 0.04% | 688 |
|
|
2022
Q1 | $954K | Sell |
7,458
-119,295
| -94% | -$14.4M | 0.01% | 2061 |
|
|
2021
Q4 | $15.6M | Buy |
126,753
+107,812
| +569% | +$14.1M | 0.15% | 90 |
|
|
2021
Q3 | $2.69M | Sell |
18,941
-36,125
| -66% | -$5.31M | 0.03% | 821 |
|
|
2021
Q2 | $8.6M | Sell |
55,066
-25,391
| -32% | -$4.11M | 0.1% | 274 |
|
|
2021
Q1 | $12.5M | Buy |
80,457
+56,971
| +243% | +$8.82M | 0.16% | 109 |
|
|
2020
Q4 | $3.51M | Sell |
23,486
-100
| -0.4% | -$14.1K | 0.05% | 628 |
|
|
2020
Q3 | $3.12M | Sell |
23,586
-171,016
| -88% | -$22.3M | 0.05% | 643 |
|
|
2020
Q2 | $22.6M | Buy |
194,602
+144,329
| +287% | +$16.6M | 0.39% | 14 |
|
|
2020
Q1 | $4.93M | Buy |
50,273
+26,197
| +109% | +$3.43M | 0.13% | 177 |
|
|
2019
Q4 | $3.5M | Sell |
24,076
-91,345
| -79% | -$12.6M | 0.06% | 444 |
|
|
2019
Q3 | $15.4M | Sell |
115,421
-109,372
| -49% | -$14.1M | 0.31% | 49 |
|
|
2019
Q2 | $25.7M | Buy |
224,793
+222,998
| +12,423% | +$26.1M | 0.47% | 10 |
|
|
2019
Q1 | $223K | Sell |
1,795
-14,737
| -89% | -$1.67M | 0.01% | 1703 |
|
|
2018
Q4 | $1.67M | Buy |
16,532
+16,223
| +5,250% | +$1.82M | 0.08% | 357 |
|
|
2018
Q3 | $39K | Sell |
309
-2,369
| -88% | -$282K | ﹤0.01% | 1741 |
|
|
2018
Q2 | $290K | Sell |
2,678
-7,416
| -73% | -$807K | 0.01% | 1111 |
|
|
2018
Q1 | $1.07M | Sell |
10,094
-7,222
| -42% | -$839K | 0.06% | 402 |
|
|
2017
Q4 | $2.03M | Buy |
17,316
+14,070
| +433% | +$1.59M | 0.11% | 224 |
|
|
2017
Q3 | $369K | Buy |
3,246
+248
| +8% | +$28.6K | 0.02% | 1015 |
|
|
2017
Q2 | $374K | Sell |
2,998
-872
| -23% | -$103K | 0.02% | 900 |
|
|
2017
Q1 | $459K | Sell |
3,870
-6,247
| -62% | -$708K | 0.03% | 682 |
|
|
2016
Q4 | $1.01M | Buy |
10,117
+8,482
| +519% | +$909K | 0.08% | 361 |
|
|
2016
Q3 | $206K | Sell |
1,635
-9,234
| -85% | -$1.14M | 0.01% | 1243 |
|
|
2016
Q2 | $1.27M | Buy |
10,869
+9,006
| +483% | +$1.02M | 0.07% | 354 |
|
|
2016
Q1 | $193K | Sell |
1,863
-13,937
| -88% | -$1.35M | 0.01% | 1238 |
|
|
2015
Q4 | $1.57M | Sell |
15,800
-11,868
| -43% | -$1.16M | 0.09% | 290 |
|
|
2015
Q3 | $2.52M | Sell |
27,668
-27,818
| -50% | -$2.79M | 0.13% | 173 |
|
|
2015
Q2 | $5.88M | Buy |
55,486
+45,548
| +458% | +$5.04M | 0.29% | 50 |
|
|
2015
Q1 | $1.13M | Buy |
9,938
+386
| +4% | +$44K | 0.06% | 516 |
|
|
2014
Q4 | $1.05M | Sell |
9,552
-10,701
| -53% | -$1.13M | 0.06% | 488 |
|
|
2014
Q3 | $1.98M | Sell |
20,253
-19,796
| -49% | -$1.95M | 0.12% | 219 |
|
|
2014
Q2 | $4.04M | Buy |
+40,049
| New | +$3.91M | 0.24% | 80 |
|
Other funds holding ZBH
Cubist Systematic Strategies's ZBH Position: Q4 2023 in Review
Cubist Systematic Strategies sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 26,734 shares — an estimated $2.98M sold.
Cubist Systematic Strategies first reported a position in ZBH in Q2 2014 and held it in 38 quarters. The position peaked at $25.7M in Q2 2019. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.
- Cubist Systematic Strategies reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 26,734 Zimmer Biomet shares in Q4 2023, an estimated $2.98M.
- Cubist Systematic Strategies first reported a position in Zimmer Biomet in Q2 2014 and held it in 38 quarters.
- Cubist Systematic Strategies's Zimmer Biomet position peaked at $25.7M in Q2 2019.
- 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.
Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.